We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$10.9B
AUM Growth
+$1.55B
Cap. Flow
+$431M
Cap. Flow %
3.95%
Top 10 Hldgs %
31.03%
Holding
358
New
19
Increased
175
Reduced
113
Closed
11

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$69.5M
2
CMCSA icon
Comcast
CMCSA
+$57.3M
3
ADP icon
Automatic Data Processing
ADP
+$50.3M
4
SPG icon
Simon Property Group
SPG
+$47.8M
5
KO icon
Coca-Cola
KO
+$42.8M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$99.3M
2
AMGN icon
Amgen
AMGN
+$63.5M
3
MKC icon
McCormick & Company Non-Voting
MKC
+$44.1M
4
MO icon
Altria Group
MO
+$37.2M
5
ABT icon
Abbott
ABT
+$24.9M

Sector Composition

Rank Sector Weight
1 Technology 20.61%
2 Healthcare 14.46%
3 Financials 13.86%
4 Industrials 10.4%
5 Consumer Staples 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPS icon
201
United Parcel Service
UPS
$87.7B
$2.24M 0.02%
+20,021
New +$2.12M
D icon
202
Dominion Energy
D
$58.8B
$2.17M 0.02%
28,324
+21,469
+313% +$1.57M
CL icon
203
Colgate-Palmolive
CL
$74.1B
$2.17M 0.02%
31,586
-270
-0.8% -$17.4K
OEC icon
204
Orion
OEC
$429M
$2.14M 0.02%
112,930
-14,633
-11% -$368K
VFC icon
205
VF Corp
VFC
$5.8B
$2.1M 0.02%
25,684
+2,552
+11% +$199K
WST icon
206
West Pharmaceutical
WST
$24.5B
$2.08M 0.02%
18,874
+250
+1% +$26K
AMZN icon
207
Amazon
AMZN
$2.94T
$2.05M 0.02%
23,000
-300
-1% -$25K
ORCL icon
208
Oracle
ORCL
$413B
$2.03M 0.02%
37,844
-659
-2% -$33.6K
ATRI
209
DELISTED
Atrion Corp
ATRI
$2.01M 0.02%
2,285
+62
+3% +$48.9K
COHR icon
210
Coherent
COHR
$65.4B
$2M 0.02%
53,786
-930
-2% -$34.4K
ZTS icon
211
Zoetis
ZTS
$32.4B
$1.99M 0.02%
19,755
-1,120
-5% -$102K
DRI icon
212
Darden Restaurants
DRI
$24.1B
$1.98M 0.02%
+16,256
New +$1.78M
PDCO
213
DELISTED
Patterson Companies, Inc.
PDCO
$1.97M 0.02%
90,321
+28,062
+45% +$622K
PRGS icon
214
Progress Software
PRGS
$1.71B
$1.96M 0.02%
+44,089
New +$1.61M
CCMP
215
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$1.92M 0.02%
17,131
+9,755
+132% +$1.01M
NSC icon
216
Norfolk Southern
NSC
$76.9B
$1.9M 0.02%
10,163
-250
-2% -$43.2K
SCL icon
217
Stepan Co
SCL
$1.45B
$1.9M 0.02%
21,675
+579
+3% +$50.2K
WAB icon
218
Wabtec
WAB
$49.9B
$1.9M 0.02%
25,736
+80
+0.3% +$5.77K
JJSF icon
219
J&J Snack Foods
JJSF
$1.72B
$1.9M 0.02%
11,938
+314
+3% +$47.9K
GMED icon
220
Globus Medical
GMED
$11B
$1.88M 0.02%
38,069
+2,766
+8% +$125K
VMI icon
221
Valmont Industries
VMI
$9.5B
$1.86M 0.02%
14,309
+404
+3% +$52.1K
MDP
222
DELISTED
Meredith Corporation
MDP
$1.85M 0.02%
+33,414
New +$1.86M
MA icon
223
Mastercard
MA
$505B
$1.83M 0.02%
7,775
+279
+4% +$60K
BF.B icon
224
Brown-Forman Class B
BF.B
$13B
$1.83M 0.02%
34,608
RAVN
225
DELISTED
Raven Industries Inc
RAVN
$1.8M 0.02%
47,018
-17,967
-28% -$681K

Similar funds

Bahl & Gaynor's Q1 2019 Portfolio in Review

As of Q1 2019, Bahl & Gaynor held 358 positions worth $10.9B, up 17% from $9.35B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor deployed $431M of net new capital in Q1 2019, opening 19 new positions and adding to 175 existing holdings. Its largest new stake was Eaton: 47,492 shares worth $3.83M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was AbbVie, an estimated $99.3M trimmed.

  • Bahl & Gaynor's largest Q1 2019 buy was Eaton: 47,492 shares worth $3.83M.
  • Bahl & Gaynor added most to Chevron in Q1 2019, an estimated $69.5M increase.
  • Bahl & Gaynor's biggest Q1 2019 reduction was AbbVie, cutting an estimated $99.3M.
  • Bahl & Gaynor fully exited Whirlpool in Q1 2019, selling an estimated $2.03M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $10.9B portfolio in Q1 2019.
  • Bahl & Gaynor opened 19 new positions and closed 11 in Q1 2019.
  • Bahl & Gaynor's portfolio value rose 17% quarter-over-quarter to $10.9B.

Based on Bahl & Gaynor's 13F filing for Q1 2019, filed 13 May 2019.